Related Experiment Video
Updated: Mar 30, 2026

Live-cell Imaging of Lysosomal Membrane Permeabilization During Necroptosis
Published on: November 14, 2025
Role of necroptosis in the pathogenesis of solid organ injury
1Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea and Westminster Hospital, London, UK.
Abstract:
Necroptosis is a type of regulated cell death dependent on the activity of receptor-interacting serine/threonine-protein (RIP) kinases. However, unlike apoptosis, it is caspase independent. Increasing evidence has implicated necroptosis in the pathogenesis of disease, including ischemic injury, neurodegeneration, viral infection and many others. Key players of the necroptosis signalling pathway are now widely recognized as therapeutic targets. Necrostatins may be developed as potent inhibitors of necroptosis, targeting the activity of RIPK1. Necrostatin-1, the first generation of necrostatins, has been shown to confer potent protective effects in different animal models. This review will summarize novel insights into the involvement of necroptosis in specific injury of different organs, and the therapeutic platform that it provides for treatment.
Insights
Necroptosis, a programmed cell death pathway, is implicated in various diseases. Inhibiting receptor-interacting protein kinase 1 (RIPK1) with necrostatins shows therapeutic potential for treating organ injury.
Area of Science:
- Molecular Biology
- Immunology
- Pathology
Background:
- Necroptosis is a regulated, caspase-independent form of cell death.
- It is dependent on receptor-interacting serine/threonine-protein (RIP) kinases.
- Necroptosis is increasingly linked to the pathology of diverse diseases.
Purpose of the Study:
- To review the role of necroptosis in organ-specific injuries.
- To explore necroptosis as a therapeutic target.
- To summarize novel insights into necroptosis signaling pathways.
Main Methods:
- Literature review of necroptosis research.
- Analysis of necroptosis involvement in disease pathogenesis.
- Evaluation of necrostatin-1 and RIPK1 inhibition strategies.
Main Results:
- Necroptosis plays a role in conditions like ischemic injury and neurodegeneration.
- RIPK1 is a key target for therapeutic intervention.
- Necrostatin-1 demonstrates protective effects in animal models.
Conclusions:
- Targeting necroptosis offers a promising therapeutic strategy.
- Inhibitors like necrostatins hold potential for treating various diseases.
- Further research into necroptosis pathways can yield novel treatments.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Apoptosis
Acute Kidney Injury II: Pathophysiology
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway

